| ASSET | MONTH | % RETURN |
|---|---|---|
Immunitybio (IBRX) | October 2023 | 84.71% |
Scholar Rock (SRRK) | October 2023 | 66.81% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | October 2023 | 46.17% |
Maase (MAAS) | October 2023 | 32% |
Cipher Mining (CIFR) | October 2023 | 28.57% |
Harmony Gold Mining (HMY) | October 2023 | 26.89% |
Apellis Pharmaceuticals (APLS) | October 2023 | 25.57% |
Eldorado Gold (EGO) | October 2023 | 23.83% |
Stride (LRN) | October 2023 | 22.37% |
Gap (GAP) | October 2023 | 21.77% |
Covista (CVSA) | October 2023 | 21.11% |
IAMGold (IAG) | October 2023 | 20.95% |
Frontline (FRO) | October 2023 | 19.62% |
FTI Consulting (FCN) | October 2023 | 18.94% |
Teekay Tankers (TNK) | October 2023 | 18.84% |
Uranium Energy (UEC) | October 2023 | 18.53% |
Belite Bio Inc ADR (BLTE) | October 2023 | 18.48% |
Erasca (ERAS) | October 2023 | 17.86% |
Impinj (PI) | October 2023 | 17.15% |
Customers Bancorp (CUBI) | October 2023 | 16.11% |
HUTCHMED DRC (HCM) | October 2023 | 14.93% |
Comstock Resources (CRK) | October 2023 | 14.55% |
Celcuity LLC (CELC) | October 2023 | 14.52% |
Kratos Defense & Security Solutions (KTOS) | October 2023 | 13.82% |
Bel Fuse B (BELFB) | October 2023 | 13.79% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.